VAERS reports by lot

Pfizer COVID-19 lot EWO169: VAERS reports

44 VAERS reports list lot EWO169 as a Pfizer COVID-19 vaccine, received between 2021-04-17 and 2022-08-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
44
Reports
23%
Marked serious
1
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)5328%
Neurological4222%
Cardiac / Cardiovascular2111%
Gastrointestinal2011%
Musculoskeletal158%
Psychiatric / Neuropsychiatric116%
Respiratory84%
Dermatological (non-injection-site)84%
Injection-site / Local reaction53%
Allergic / Anaphylactic32%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York6
California5
North Carolina5
Ohio4
New Mexico2
Texas2
South Carolina2
Wisconsin2
Pennsylvania2
Georgia1
Tennessee1
Missouri1

Reports by month received

2021-045
2021-056
2021-067
2021-073
2021-087
2021-091
2021-104
2021-121
2022-013
2022-021
2022-031
2022-041
2022-061
2022-071
2022-082

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.